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Available online 1 February 2014AbstractObjectives: To compare simple enucleation (SE) and standard partial nephrectomy (SPN) in terms of surgical results in a multicenter dataset
(RECORd Project).
Materials and methods: patients treated with nephron sparing surgery (NSS) for clinical T1 renal tumors between January 2009 and January
2011 were evaluated. Overall, 198 patients who underwent SE were retrospectively matched to 198 patients who underwent SPN. The SPN
and SE groups were compared regarding intraoperative, early post-operative and pathologic outcome variables. Multivariable analysis was
applied to analyze predictors of positive surgical margin (PSM) status.
Results: SE was associated with similar WIT (18 vs 17.8 min), lower intraoperative blood loss (177 vs 221 cc, p ¼ 0.02) and shorter oper-
ative time (121 vs 147 min; p < 0.0001). Surgical approach (laparoscopic vs. open), tumor size and type of indication (elective/relative vs
absolute) were associated with WIT >20 min. The incidence of PSM was significantly lower in patients treated with SE (1.4% vs 6.9%;
p ¼ 0.02). At multivariable analysis, PSM was related to the surgical technique, with a 4.7-fold increased risk of PSM for SPN compared to
SE. The incidence of overall, medical and surgical complications was similar between SE and SPN.* Corresponding author. Department of Neurosciences, Sciences of
Reproduction and Odontostomatology, University Federico II of Naples,
Italy. Tel.: þ39 081 7462504; fax: þ39 081 5452959.
E-mail address: ferdinando-fusco@libero.it (F. Fusco).
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763N. Longo et al. / EJSO 40 (2014) 762e768Conclusions: Type of NSS technique (SE vs SPN) adopted has a negligible impact on WIT and postoperative morbidity but SE seems pro-
tective against PSM occurrence.
 2014 Elsevier Ltd. All rights reserved.
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In the last decades, a net increase in the detection of
small incidental renal masses has been observed and
nephron-sparing surgery (NSS), aimed to preserve the
largest amount of healthy renal tissue while obtaining
similar oncologic outcomes of radical nephrectomy (RN),
has become more popular.1,2 Standard partial nephrectomy
(SPN) consisting in the tumor removal with an adequate
safety margin of health parenchyma is still considered as
the gold standard technique.3 In the last decades, some Au-
thors demonstrated that healthy parenchyma surrounding
the tumor can be limited to a few millimeters without
compromising the oncologic safety of partial nephrectomy
(PN).4 Although the mean thickness of the safety margin
surrounding the tumor ranges from 2.5 mm to 5 mm,
some studies clearly demonstrated that the minimum values
of thickness of the safety margin ranges between 0 mm and
1 mm above all at the bottom of the tumor.1 This variability
of the thickness of the safety margin might be influenced by
several anatomical and topographic tumor features. In this
context, some Authors proposed the simple enucleation
(SE) of the tumor as alternative to the SPN.5 This surgical
procedure consists of a blunt dissection of the renal tumor
following a plane between the capsule and the healthy renal
tissue, without including any visible normal renal paren-
chyma. Recently, a multicenter, retrospective analysis re-
ported similar cancer specific and recurrence free survival
rates after SE and SPN.5 However, in the previous study
no data concerning perioperative outcomes were reported.
The objective of present study was to compare intraopera-
tive and early post-operative outcomes observed in two
recent cohort of patients who underwent SE or SPN for
parenchymal renal masses.
Materials and methods
The Italian Registry of Conservative Renal Surgery
(RECORd Project) is an observational multicenter prospec-
tively derived dataset promoted by the Leading Urological
No profit foundation Advanced research (LUNA) of the
Italian Society of Urology. Patients who underwent open
or laparoscopic PN for clinical T1 renal tumors between
January 2009 and January 2011 at 19 urological Centers
were collected in the registry and included into the study.
The study was approved by the Internal Board Committee
and all patients signed a specific informed consent. Exclu-
sion criteria were: incomplete data and presence ofsynchronous metastatic disease. All the clinical records
were collected in an online database consisting of 5 main
sections (demographic, preoperative, intraoperative, post-
operative and histopathological findings). Performance sta-
tus was defined according to the Eastern Cooperative
Oncology Group (ECOG) criteria.6 Mode of presentation
of the tumor was defined according to the Patard classifica-
tion.7 Moreover, tumors were classified according to their
location on the longitudinal plane (polar or mesorenal).
Each tumor was also classified into three growth pattern
categories: 1) prevalently (¼50%) exophytic, 2) prevalently
endorenal (<50% exophytic), and 3) entirely endorenal. In-
dications to NSS were defined as elective (localized unilat-
eral renal mass with healthy contralateral kidney), relative
(localized unilateral renal mass with concomitant co-
morbidities such as diabetes, hypertension or lithiasis)
and absolute (bilateral tumors, multiple tumors, moderate
to severe chronic kidney disease or tumors involving soli-
tary kidneys). NSS was performed as SPN or SE according
to surgeon’s and center’s preferences independently form
tumor characteristics and surgical complexity. SPN con-
sisted in the complete tumor excision with of an additional
visible margin of healthy renal parenchyma. SE was
defined as a blunt tumor excision performed without a
visible rim of parenchyma tissue around tumor pseudocap-
sule.5 Haemostasis of the excision bed was achieved with
different haemostatic agents (Floseal, Tachosil,
Cianacril, Tabotamp and fibrin glue). The following in-
traoperative data were recorded: type of surgical approach
(open or laparoscopic), NSS technique (SPN or SE), oper-
ative time, presence or absence of ischemia, ischemia time,
intraoperative blood loss, and intra-and early post-operative
complications. All surgical specimens were processed by
experienced uro-pathologists at each institution. All the tis-
sue blocks were embedded in paraffin, sectioned, and
stained with hematoxylineosin. Microscopic evaluation al-
lowed the assignment of histological type and nuclear
grade, pathological stage, and evaluation of surgical mar-
gins. Tumors were clinically and pathologically staged ac-
cording to the American Joint Committee on Cancer
(AJCC) TNM classification.8 Heidelberg and Fuhrman
classifications were used to assign the tumor histologic
subtype and the nuclear grade, respectively.9,10 For surgical
margins evaluation the specimens (both SE and SPN spec-
imens) were fixed in 10% buffered formalin, and grossly
analyzed. The size, the colour, the gross aspect (solid to
cystic) were recorded, and the surgical margin was marked
with ink. After tumor dissection, samplings were
Table 1
Preoperative and intra-operative data.
Standard
partial
nephrectomy
Simple
enucleation
p
Age
Mean, SD 62.4 (12.2) 62.8 (11.5) n.s.
65 n, (%) 95 (48.0%) 99 (50.0%) n.s.
>65 n, (%) 103 (52.0%) 99 (50.0%)
BMI, Mean (SD) 26.4 (3.9) 26.5 (3.9) n.s.
Gender
Male n, (%) 141 (71.2%) 124 (62,6%) n.s.
Female n, (%) 57 (28.8%) 74 (37.4%)
Tumor side
Right n, (%) 118 (59.6%) 87 (43.9%) 0.007
Left n, (%) 79 (39.9%) 109 (55%)
Bilateral n, (%) 1 (0.5%) 2 (1.1%)
ECOG
0 n, (%) 122 (61.6%) 116 (58.6%) n.s
1 n, (%) 76 (38.4%) 82 (41.4%)
Symptoms at diagnosis
Asymptomatic n, (%) 161 (81.3%) 172 (86.9%) n.s.
Symptomatic n, (%) 37 (18.7%) 26 (13.1%)
Clinical tumor size,
mean (SD)
3.0 (1.4) 3.0 (1.2) n.s.
Clinical tumor size
4 cm n, (%) 168 (84.8%) 166 (83.8%) n.s.
4.1e7 cm n, (%) 30 (15.2%) 32 (16.2%)
Tumor location
Polar n, (%) 140 (70.7%) 137 (69.2%) n.s.
Mesorenal n, (%) 58 (29.3%) 61 (30.8%)
Type of indication
Elective n, (%) 166 (83.8%) 172 (86.9%) n.s.
Relative n, (%) 16 (8.1%) 10 (5.0%)
Absolute n, (%) 16 (8.1%) 16 (8.1%)
Tumor growth pattern
50% exophytic n, (%) 152 (76.8%) 149 (75.2%) n.s.
>50% endophytic n, (%) 44 (22.2%) 47 (23.8%)
Completely
endorenal n, (%)
2 (1.0%) 2 (1.0%)
Preop GFR using MDRD,
mean (SD)
82.3 (21.9) 85.6 (23.0) n.s.
Preoperative HB level,
mean (SD)
14.1 (1.5) 14.2 (1.4) n.s.
Surgical approach
Open n, (%) 133 (67.2%) 125 (63.1%) n.s.
Laparoscopic n, (%) 65 (32.8%) 73 (36.9%)
Hilar clamping
Yes n, (%) 122 (61.7%) 138 (69.7%) n.s.
No n, (%) 76 (38.3) 60 (30.3%)
Ischemic time (min)
mean (SD)
17.8 (6.9) 18 (5.5) n.s.
Operative time (min)
mean (SD)
147 (42) 121 (44) p < 0.0001
Intraoperative blood
loss (cc), mean (SD)
221 (131) 177 (128) p ¼ 0.02
SD: Standard deviation.
BMI: Body mass index.
ECOG: Eastern Cooperative Oncology Group.
Hb: Hemoglobin.
GFR: Glomerular filtration rate.
MDRD: Modification of diet in renal disease.
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renal parenchyma, and surgical edges were comprised
and further blocks where tumor, renal capsule, and peritu-
moral fat were enclosed. The margin was considered posi-
tive when tumor tissue was marked with ink. The margin
was considered negative when no-neoplastic renal tissue
was observed between tumor tissue and the line of ink.
All postoperative medical and surgical complications
occurring within 30 days from surgery were recorded.
The severity of surgical complications was graded accord-
ing to the modified Clavien classification system.11 In the
present study a propensity score matching was performed
to adjust for preoperative variables using R Project. This
is a method that permits to control for imbalances in con-
founding factors among discrete study cohorts.12,13 A pro-
pensity score was calculated for each patient using
multivariable logistic regression based upon the covariates:
clinical tumor size (continue variable), type of indication,
surgical approach, tumor growth pattern and tumor loca-
tion. The matching was carried out with a 1:1 ratio with
respect to the treatment (SPN vs SE) with a C statistic of
0.9. Continuous variables were reported as mean, standard
deviation (SD), median and range as appropriate. Categor-
ical variables were reported as percentages. The Student
t test was used to compare continuous variables. The Pear-
son chi square test was used to compare categorical vari-
ables. The SPN and the SE group were compared
regarding pre-operative, intra-operative, pathologic and
early post-operative outcome variables. Multivariable lo-
gistic regression models were applied to assess predictors
of positive surgical margin (PSM) status. Statistical signif-
icance was set as p ¼ 0.05. All reported p values are two
sided. Analyses were performed with SPSS version 17.0
(SPSS Inc, Chicago, IL, USA) by two of the authors
(AM, AM).
Results
Overall, 198 patients that underwent SPN were matched
with 198 patients that underwent SE. Demographics and tu-
mors’ characteristics are reported in Table 1. The two study
groups were comparable in terms of: mean age, body mass
index, gender, ECOG performance status, clinical tumor
size, symptoms at diagnosis, type of indication, growth
pattern, tumor location, glomerular filtration rate, hemoglo-
bin level. The only difference that emerged between the
two groups was the side of the tumor. Most patients in
both groups underwent open surgery, with only 36.9% of
SE and 32.8% of SPN performed laparoscopically (Table
1). Operative time was significantly lower in the SE group
(121 min vs 147 min; p < 0.0001). Hilar clamping was
done in 122 patients (61.7%) in the SPN group and in
138 patients (69.7%) in the SE group. Mean ischemia
time was 18 min and 17.8 min in the SE and SPN groups,
respectively ( p: not significant). WIT was ¼ 20 min in 103
patients (74.6%) in the SE group and in 92 patients (75.4%)
Table 2
Univariate analysis for WIT >20 min in 260 patients that had NSS with
hilar clamping.
WIT 20 min WIT >20 min P
Age, mean (SD) 62.3 (12.1) 61.6 (12.8) 0.68
Tumor size (cm),
mean (SD)
3.1 (1.3) 3.7 (1.4) 0.0004
Surgical approach,
n. (%)
<0.0001
VLP 48 (53.3%) 42 (46.7%)
Open 147 (86.5%) 23 (13.5%)
Surgical technique,
n. (%)
0.89
SE 103 (74.6%) 35 (25.4%)
PN 92 (75.4%) 30 (24.6%)
Tumor growth pattern,
n. (%)
0.94
50% exophytic 137 (74.9%) 46 (25.1%)
>50% endophytic 58 (75.3%) 19 (24.7%)
Tumor location, n. (%) 0.43
Polar 110 (76.9%) 33(23.1%)
Mesorenal 85 (72.6%) 32 (27.4%)
Symptoms at diagnosis,
n. (%)
0.93
Asymptomatic 161 (74.9%) 54 (25.1%)
Symptomatic 34 (75.6%) 11 (24.4%)
Indication, n. (%) 0.07
Elective 171 (76.7%) 52 (23.3%)
Relative 12 (80%) 3 (20%)
Absolute 12 (54.5%) 10 (45.5%)
Indication, n. (%) 0.02
Elective/relative 183 (76.9%) 55 (23.1%)
Absolute 12 (54.5%) 10 (45.5%)
Table 3
Pathological data.
Standard PN SE P
Pathological size
Mean (SD) 3.2 (1.3) 3.1 (1.2) n.s.
4 cm n, (%) 158 (79.8%) 160 (80.8%) n.s.
4.1e7 cm n, (%) 38 (19.2%) 37 (18.7%)
>7 cm n, (%) 2 (1.0%) 1 (0.5%)
Histotype
Malignant n, (%) 145 (73.2%) 147 (74.2%) n.s
Benign n, (%) 53 (26.8%) 51 (25.8%)
Hystotype
Clear cell n, (%) 103 (52%) 102 (51.5%) n.s.
Papillary n, (%) 19 (9.6%) 28 (14.1%)
Cromophobe n, (%) 20 (10.1%) 17 (8.6%)
Not classified n, (%) 3 (1.5%) 0
Oncocitome n, (%) 26 (13.1%) 26 (13.1%)
Angiomyolipoma n, (%) 19 (9.6%) 16 (8.1%)
Others (Benign) n, (%) 8 (4.1%) 9 (4.6%)
PT stage
pT1a n, (%) 112 (77.2%) 115 (78.2) n.s.
pT1b n, (%) 27 (18.6%) 25 (17)
pT2 n, (%) 2 (1.4) 0
pT3a n, (%) 4 (2.8%) 6 (4.1)
pT3b n, (%) 0 1 (0.7%)
Surgical margins
Negative n, (%) 135 (93.1%) 145 (98.6%) p ¼ 0.02
Positive n, (%) 10 (6.9%) 2 (1.4%)
Coagulative necrosis
Absent n, (%) 123 (84.8%) 139 (94.6%) p ¼ 0.01
Present n, (%) 22 (15.2%) 8 (5.4%)
Tumor grade
1-2 n, (%) 112 (78.9%) 127 (86.4%) n.s.
3-4 n, (%) 30 (21.1) 20 (13.6%)
Sarcomatoid
differentiation
Absent n, (%) 144 (99.3%) 146 (99.3%) n.s.
Present n, (%) 1 (0.7%) 1 (0.7%)
765N. Longo et al. / EJSO 40 (2014) 762e768in the SPN group. Univariable analysis showed the
following factors to impact WIT: tumor size, surgical
approach, type of indication (Table 2). Intraoperative blood
loss was significantly lower in the SE group (177 cc vs
221 cc, p ¼ 0.02). Pathology results are reported in
Table 3. In both groups most tumors were malignant with
the clear cell form being the most frequent hystotype. Path-
ological stage was mainly pT1a. Significant differences
emerged between the two groups in terms of presence of
coagulative necrosis and PSM. The incidence of PSM
was significantly lower in patients treated with SE
compared to SPN (1.4% vs 6.9%; p ¼ 0.02). Multivariable
analysis demonstrated that the surgical technique was the
only independent predictor of PSM (Table 4). The overall
incidence of early medical and surgical complications
was similar in both groups (42/198, 24%, in SPN vs. 37/
198, 18.7%, in SE group; p ¼ n.s.). Medical complications
were reported in 13/198 (6.6%) and 7/198 (3.5%) patients
in the SPN and SE group, respectively ( p ¼ n.s.). Surgical
Clavien II complications were reported in 11 (5.6%) pa-
tients in the SPN and in 16 (8%) patients in the SE group
( p ¼ n.s.) Surgical Clavien III complications were reported
in 9 (8%) patients in the SPN and in 10 (5%) patients in the
SE group ( p ¼ n.s.). There were not Clavien grade IV and
V complications.Comments
Recently, the interest for NSS has increased as several
studies have demonstrated the oncologic equivalence with
radical nephrectomy (RN) for the treatment of T1
RCC.14,15 Various NSS techniques have been described. In
1950, Vermooten first suggested that peripheral renal tumors
could be locally excised by leaving a margin of healthy pa-
renchyma around the tumor of at least 1 cm.16,17 Further
studies have demonstrated that surgical margin involvement
does not necessarily indicate residual disease or adverse
prognosis.18 To date, there are no established recommenda-
tions regarding the optimal width of healthy surgical margin
during NSS. The European Association of Urology (EAU)
Guidelines recommend the presence of a minimal, but not
better specified, tumor-free surgical margin surrounding
the resected tumor.19 In recent years, data has emerged
demonstrating good oncologic, functional and perioperative
outcomes of SE.5,20,21 To our knowledge, this study repre-
sents the first multicenter clinical study comparing SE and
standard PN in terms of intraoperative, early postoperative
and pathological outcomes in patients with clinical T1 renal
Table 4
Univariate and multivariate analysis for positive surgical margins in 292 malignant tumors.
Univariate analysis Multivariate analysis for surgical margin
Negative surgical
margins
Positive surgical
margins
p RR 95% CI p
Age, mean (SD) 62.5 (12) 66.5 (7) 0.25 e e e
Tumor size (cm) , mean (SD) 3.2 (1.3) 3.2 (1.5) 0.90 e e e
Tumor growth pattern, n. (%) 0.50 e e e
50% exophytic 209 (95.4%) 10 (4.6%)
>50% endophytic 71 (97.3%) 2 (2.7%)
Tumor location, n. (%) 0.21 e e e
Polar 164 (93.7%) 9 (6.3%)
Mesorenal 116 (97.5%) 3 (2.5%)
Symptoms at diagnosis, n. (%) 0.90 e e e
Symptomatic 43 (95.6%) 2 (4.4%)
Asymptomatic 237 (96%) 10 (4%)
Indication, n. (%) 0.03 3.1 0.70e13.68 0.14
Elective/Relative 259 (96.6%) 9 (3.4%)
Absolute 21 (87.5%) 3 (12.5%)
Surgical approach, n. (%) 0.25 e e e
VLP 90 (97.8%) 2 (2.2%)
Open 190 (95%) 10 (5%)
Surgical technique, n. (%) 0.02 4.7 1.00e22.45 0.050
SE 145 (98.6%) 2 (1.4%)
PN 135 (93.1%) 10 (6.9%)
PT stage n, (%) 0.90 e e e
pT1a 218 (96%) 9 (4%)
pT1b 50 (96.1%) 2 (3.9%)
pT2 2 (100%) 0
pT3a 9 (90%) 1 (10%)
pT3b 1 (100%) 0
Tumor grade n, (%) 0.03 2.6 0.74e9.31 0.14
1e2 n, (%) 232 (97.1%) 7 (2.9%)
3e4 n, (%) 45 (90%) 5 (10%)
Coaugulative
necrosis n, (%)
0.91 e e e
Absent 251 (95.8%) 11 (4.2%)
Present 29 (96.7%) 1 (3.3%)
Sarcomatoid
differentiation n, (%)
0.77 e e e
Absent 278 (96.9%) 12 (3.1%)
Present 2 (100%) 0
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surgical margins are negative, and (3) no major complica-
tions are observed.21 In the present series, the duration of
ischemia was similar in both groups with mean ischemia
time being<20min.Mottrie et al. demonstrated that surgical
experience, as well as the anatomic and pathologic character-
istics of the treated tumors were independent predictors of
WIT>20 min.22 The results of a recent multicenter, interna-
tional study confirmed previous data and demonstrated that
anatomic aspects such as polar (superior/inferior vs. middle)
and rim tumor (lateral vs. medial) location, the relationship
between tumor and collecting system or renal sinus, and
the exophytic rate of the tumor were able to predict WIT
>20 min regardless of the clinical tumor size.23 In this study,
univariable analysis showed that tumor size, surgical
approach and type of indications were associated with WIT
>20 min. Overall, 46.7% of patients that underwent laparo-
scopic surgery and 13.5% of patients that underwent opensurgery had a WIT> 20 min. According to EAU Guidelines,
open NSS currently remains the standard of care and laparo-
scopicNSS (LNSS) should be performed by experienced sur-
geons.19 These results are in line with published data.19 The
achievement of negative surgical margins is one of the major
challenges of NSS. PSM after NSS occurs in 2e8% of pa-
tients.24 The presence of PSM as risk factor for disease recur-
rence after NSS is still a matter of debate, however, it should
prompt more frequent and intensive surveillance.25 The need
to excise a rim of healthy parenchyma to avoid the risk of
PSM and local recurrence is controversial. The incidence
of PSMs in the present study is within the published ranges.
Unexpectedly, in the present study the incidence of PSMwas
significantly lower in patients treated with SE and 4.7 higher
in pts undergoing SPN. Moreover, results frommultivariable
analysis showed that surgical technique was the only inde-
pendent predictor of PSM. Although the low PSM rate after
SE is in accordance with previously published data,5 this
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ered very carefully, as many factors not included in themulti-
variable analysis could have influenced our results, including
the different experience in SE or SPN of surgeons and pathol-
ogists involved in the different centers. Furthermore,
although statistically significant, the lower incidence of
PSM in the SE group is numerically very low (8pts), and
might become even less significant in larger series. Neverthe-
less, present data should be regarded as a proof against a clear
oncological superiority of SPN vs SE, that although expect-
able and intuitive, is far from being demonstrated. Several
circumstances might promote the occurrence of a PSM,
such as poor intraoperative visibility and orientation, and
infiltrating tumor pattern.26 Results from the present study
could be also explained by the fact that during SE, a natural
cleavage plane between the tumor pseudocapsule and the
normal parenchyma is followed thus allowing for a blunt
dissection without entering the tumor.27,28 The oncologic
safety of blunt tumor enucleation of RCC has been demon-
strated by pathological studies which have described the
presence of an inflammatory tissue with a median thickness
of 1 mm which allow the presence of negative surgical mar-
gins also for tumors microscopically extending beyond the
tumor capsule.27 This thin layer of normal tissue is present
as ‘leopard spots’ on the intact tumor capsule, and always
presents in case of neoplastic penetration of the capsule
into the kidney tissue.27 NSS is technically more challenging
than RN and therefore has a higher complication rate. Liter-
ature data concerning NSS morbidity are extremely variable
and the overall complication rate ranges between 4% and
37%.29 However, in the past decade, better patient selection,
operating techniques, peri-operative care, and surgical expe-
rience allowed a reduction of complications.27 Intraoperative
blood loss is a relevant issue during NSS. Results from the
present study demonstrate significantly lower operative
times and intraoperative blood loss in patients treated with
SE although this reduced bleeding was clinically not rele-
vant. These results may be explained by the existence of a
natural cleavage plane dissection plane between the tumor
capsule and the normal parenchyma. Overall, the number
of patients with complications in the present study was
within the published ranges with similar early complication
rate between the two groups. The incidence of surgical and
medical complications did not differ significantly between
SPN and SE. This study represents the first large multicenter,
non randomized matched-pair analysis aiming to compare
the perioperative outcomes of SE versus SPN in clinical T1
renal tumors. We acknowledge some limitations to the pre-
sent study: the lack of randomization, the lack of nephromet-
ric classification system and the lack of central pathologic
review that did not allow the evaluation of the thickness of
peritumoral tissue in either surgical procedure, with the
aim of confirming histologically the kind of surgical proce-
dure performed in each case; the type of surgical technique
adopted was reviewed from each institutional database orig-
inated from copies of original operative reports. Moreoverthe choice of which NSS technique to perform was based
on surgeon preference.
Conclusions
In a large multicenter prospectively derived dataset, SE
is associated with shorter operative time and lower blood
loss if compared to SPN. The two techniques are associated
with similar WIT and similar incidence of overall, surgical
and medical complications. The incidence of PSMs seems
to be higher with SPN. The latter results need to be
confirmed in further randomized studies aimed to minimize
the possible confounding factors implied by a multicentre,
observational study design.
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